share_log

德琪醫藥-B：截至2024年4月30日止月份之股份發行人的證券變動月報表

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

Hong Kong Stock Exchange ·  May 3 04:51
Summary by Moomoo AI
德琪醫藥有限公司於2024年5月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年4月30日的情況。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額為200,000美元。此外，公司的股份期權計劃中，2019股權激勵計劃及2020股權激勵計劃分別註銷了223,580股和343,600股期權。經註銷後，2019計劃及2020計劃的股份期權結存分別為14,104,046股和15,425,620股。本月內沒有因行使期權而得到的資金。報告中未提及其他發行股份的協議或安排，以及與香港預託證券相關的資料。
德琪醫藥有限公司於2024年5月3日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年4月30日的情況。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額為200,000美元。此外，公司的股份期權計劃中，2019股權激勵計劃及2020股權激勵計劃分別註銷了223,580股和343,600股期權。經註銷後，2019計劃及2020計劃的股份期權結存分別為14,104,046股和15,425,620股。本月內沒有因行使期權而得到的資金。報告中未提及其他發行股份的協議或安排，以及與香港預託證券相關的資料。
DEKI PHARMACEUTICALS LIMITED FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 3 MAY 2024, COVERING THE SITUATION AS OF 30 APRIL 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, totaling $200,000. In addition, 223,580 shares and 343,600 share options were written off in the Company's Stock Option Plan 2019 and Stock Incentive Plan 2020, respectively. After the write-off, the stock options under the 2019 Plan and the 2020 Plan were outstanding for 14,104,046 shares and 15,425,620 shares, respectively. No funds received during the month due to exercise options. The report does not mention other agreements or arrangements for issuing shares and information relating to Hong Kong pre-trust securities.
DEKI PHARMACEUTICALS LIMITED FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 3 MAY 2024, COVERING THE SITUATION AS OF 30 APRIL 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and deposits at the end of this month, with a face value of $0.0001 per share, totaling $200,000. In addition, 223,580 shares and 343,600 share options were written off in the Company's Stock Option Plan 2019 and Stock Incentive Plan 2020, respectively. After the write-off, the stock options under the 2019 Plan and the 2020 Plan were outstanding for 14,104,046 shares and 15,425,620 shares, respectively. No funds received during the month due to exercise options. The report does not mention other agreements or arrangements for issuing shares and information relating to Hong Kong pre-trust securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more